Search results
For some endometriosis-related ovarian cancers, timing is everything
Medical Xpress· 2 days agoClear cell ovarian carcinoma comprises 5%–12% of ovarian cancer cases and is resistant to chemotherapy. Endometrioid ...
Gene variants foretell the biology of future breast cancers, study finds
Medical Xpress· 1 hour ago"Apart from a few highly penetrant genes that confer significant cancer risk, the role of heredity factors remains poorly understood, and most malignancies are assumed to ...
Targeting 'monster cancer cells' could reduce recurrence rates after cancer therapy
Medical Xpress· 2 days agoBoth types of therapy put cancer cells under stress, with the goal of causing them to self-destruct. Recently, scientists have begun to look at the role of polyploid giant ...
Seattle researchers explore causes of ovarian cancer: HealthLink
KING5 Seattle· 6 days agoMedical researchers in Washington state are looking deeper into what causes ovarian cancer, thanks...
Juncell Therapeutics Announces Clinical Data of GC203 TIL therapy in Ovarian Cancer at ASCO 2024
KTLA-TV Los Angeles· 6 days ago(Juncell Therapeutics), a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers, announced latest clinical research results ...
Mercy Bioanalytics Pushing Forward with Plans to Market Ovarian Cancer Blood Test
GenomeWeb News· 2 days agoExtracellular vesicle diagnostics firm Mercy Bioanalytics is making progress in its plans to market and eventually garner US Food and Drug Administration approval for a novel ovarian ...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoTILT-123 is an oncolytic adenovirus featuring tumour necrosis factor alpha (TNFα) and interleukin-2...
How To Prevent Breast Cancer
Health via Yahoo News· 2 days agoThis implies that age is also a risk factor for this condition. Other... risk factors for breast cancer may include: Having a personal or family history...
... in Combination with Garsorasib in Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
WKBN 27 Youngstown· 10 hours ago...May 30, 2024 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company developing innovative therapies against tumor-treatment resistance and metastasis, today announced results from the Phase Ib/II clinical trial of ifebemtinib, the company's focal adhesion kinase (FAK) inhibitor,...
Breast Cancer in Young Women: Rates Rise, Guidelines Shift
WebMD· 1 day agoBreast cancer does not discriminate based on age. Women across the world are increasingly becoming diagnosed with breast cancer under the age of 40. Researchers ...